Pharmacotherapy of obesity: Available medications and drugs under investigation

Obesity is a chronic disease with a continuously rising prevalence that currently affects more than half a billion people worldwide. Energy balance and appetite are highly regulated via central and peripheral mechanisms, and weight loss triggers a homeostatic response leading to weight regain. Lifes...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Metabolism, clinical and experimental clinical and experimental, 2019-03, Vol.92, p.170-192
Hauptverfasser:	Pilitsi, Eleni, Farr, Olivia M., Polyzos, Stergios A., Perakakis, Nikolaos, Nolen-Doerr, Eric, Papathanasiou, Aimilia-Eirini, Mantzoros, Christos S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Liraglutide Lorcaserin Naltrexone/bupropion Obesity Orlistat Personalized therapy phentermine/topiramate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!